Dr. Mungo is passionate about using research, advocacy, and capacity-building to pursue global women’s health equity. Her primary research is focused on increasing access to effective, evidence-based cervical cancer prevention in low-income countries, including investigating resource-appropriate and effective methods of treating cervical precancer, especially among women living with HIV in low-resource settings. She is also studying dysplasia treatment outcomes following thermal ablation in low-resource settings.
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar effective September 13, 2021. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.